Oxbryta Европска Унија - Словачки - EMA (European Medicines Agency)

oxbryta

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Betaloc 1 mg/1 ml Словачка - Словачки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

betaloc 1 mg/1 ml

recordati industria chimica e farmaceutica s.p.a., taliansko - metoprolol - 77 - sympatholytica